Novartis Ag (NVS) Return on Sales (2009 - 2026)
Novartis Ag (NVS) posted Return on Sales of 0.0% for Q2 2026, down 14.81% sequentially from 0.0% in Q1 2026, and little changed YoY from 0.0% in Q2 2025.
Novartis Ag (NVS) Return on Sales (2009 - 2026) Analysis & Trends
Novartis Ag has reported Return on Sales for 18 years, with the latest figure at 0.0% in Q2 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Sales fell to 0.0% in Q2 2026 per NVS's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Sales peaked at 1323.01% in Q1 2022 and troughed at 0.0% in Q2 2023.
- A 5-year average of 77.83% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2022 and 2023: Return on Sales surged 82474 bps in 2022, then slumped 132301 bps in 2023.
- Over 5 years, Return on Sales stood at 0.0% in 2022, then sank by 34 bps to 0.0% in 2023, then surged by 1562 bps to 0.0% in 2024, then slipped by 18 bps to 0.0% in 2025, then decreased by 16 bps to 0.0% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 0.00% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 0.00% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 0.00% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 0.00% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 0.00% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 0.00% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -0.01% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 0.00% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.00% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.02% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.01% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 1,323.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -0.44% |
| Jun 30, 2021 | 0.00% |